Use of fluoroquinolones and the risk of aortic and mitral regurgitation: A nationwide case-crossover study
An‐Hsun Chou(Chang Gung University), Shao-Wei Chen(Chang Gung University), Kuo‐Chun Hung(Chang Gung Memorial Hospital), Dong‐Yi Chen(Chang Gung University), Fu‐Chih Hsiao(Chang Gung University), Chia‐Pin Lin(Chang Gung University), Yi‐Hsin Chan(Memorial Hospital of South Bend), Chun-Yu Chen(Kaohsiung Veterans General Hospital), Pao‐Hsien Chu(Chang Gung University), Yu‐Ting Cheng(Chang Gung Memorial Hospital), Victor Chien‐Chia Wu(University of California, San Francisco)
Cited by 3
Related Papers
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
|Thrombosis and Haemostasis|2021|476
Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular Arrhythmia
|Clinical Toxicology|2006|279
Atrial fibrillation and its arrhythmogenesis associated with insulin resistance
|Cardiovascular Diabetology|2019|186
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
|CHEST Journal|2019|119
Luteolin attenuates neutrophilic oxidative stress and inflammatory arthritis by inhibiting Raf1 activity
|Biochemical Pharmacology|2018|106